Bridging Animal & Human Models of Exercise-induced Visual Rehabilitation

Status Active, not recruiting

Clinical Trial Summary

This study will determine whether blood biomarker changes predict sight-saving benefits of exercise.

Clinical Trial Description

Investigators of the Atlanta VA Center for Visual and Neurocognitive Rehabilitation (CVNR) find a very high prevalence of blinding diseases in the aging Veteran population. There are few treatments for the disorders that threaten our Veterans' eyesight. The work proposed here is the first step in determining whether exercise can be used by aging Veterans as an inexpensive and self-controlled therapy for vision loss. In order to translate exercise therapy for vision into the clinic, the investigators need to identify biomarkers that can be used to predict visual benefits. Though human and animal studies show that aerobic exercise is beneficial to specific central and peripheral nervous system functions, effects on the retina and vision were unknown until the investigators recently discovered that treadmill exercise directly protects retinal neurons in mice undergoing light-induced retinal degeneration (LIRD). The investigators found that exercise increased levels of brain-derived neurotrophic factor (BDNF) a blood protein in the blood, brain and eyes, whereas treatment of mice with a BDNF inhibitor prevented the protective effects of exercise. For this study, the investigators will assess visual outcomes and serum biomarkers (e.g, BDNF) in 60 subjects age 18-89 before, during, and after aerobic exercise. Subjects currently enrolled in a 12-week study (under IRB 56726) examining the effects of aerobic exercise on cognition will have visual testing (ERG, visual acuity, contrast sensitivity, and OCT) and blood collection prior to, during and after the standardized 12-week aerobic exercise regimen to determine whether circulating biomarker levels and visual outcomes are correlated and whether biomarker levels are altered as predicted in animal studies. This study will determine whether biomarker changes predict sight-saving benefits of exercise. As opposed to surgery or pharmacological treatments, exercise programs provide a means for Veterans to exert some control over their visual disease progression and will increase their overall health. ;

Study Design

Related Conditions & MeSH terms

Vision Disorders

Clinical Trial Details

NCT number	NCT02911805
Study type	Interventional
Source	VA Office of Research and Development
Contact
Status	Active, not recruiting
Phase	N/A
Start date	June 10, 2015
Completion date	March 31, 2024

View Details

See also
Status	Clinical Trial	Phase
Active, not recruiting	`NCT03872479` - Single Ascending Dose Study in Participants With LCA10	Phase 1/Phase 2
Active, not recruiting	`NCT02595502` - Clinical Evaluation of Two Silicone Hydrogel Daily Disposable Contact Lenses	N/A
Completed	`NCT02485054` - A Predictive Score for the Ischemic Etiology of a Transient Visual Disturbances (VASCO)
Completed	`NCT00985231` - Performance Evaluation of Contact Lenses Among a Population of Adapted Contact Lens Wearers	N/A
Recruiting	`NCT05208658` - Characteristics of the Vergence Responses of Binocularly Normal Subjects After a Vision Therapy Protocol	N/A
Recruiting	`NCT06077682` - Cycloplegic Refraction in Pediatric Patients With Esotropia	Phase 4
Active, not recruiting	`NCT04123626` - A Study to Evaluate the Safety and Tolerability of QR-1123 in Subjects With Autosomal Dominant Retinitis Pigmentosa Due to the P23H Mutation in the RHO Gene	Phase 1/Phase 2
Recruiting	`NCT04693247` - Handheld Device Compared With a Standard Eye Care Diagnostic Device in Measuring Ophthalmic Refraction	N/A
Recruiting	`NCT06451172` - Novel Antisense Oligonucleotide Eye Drops for Treating Antibiotic-Resistant Bacterial Keratitis	Early Phase 1
Completed	`NCT01318577` - Study of A New Contact Lens Cleaning and Disinfecting Solution	N/A
Completed	`NCT03763721` - The ADVISE Study: Advanced Visualization In Corneal Surgery Evaluation	N/A
Completed	`NCT05602402` - To Evaluate the Efficacy and Safety of CAEP-01 on Eye Strain in Children With Heavy Screen Use	N/A
Not yet recruiting	`NCT06085430` - Kubota Glass Parameter Refinement Study	N/A
Completed	`NCT04347564` - Usability of the Software MacuFix for the Categorization of Metamorphopsia
Completed	`NCT01698788` - Effect of Intraoperative Dexamethasone Implant in Taut Posterior Hyaloid Removal in Diabetic Macular Edema	N/A
Completed	`NCT01546402` - Intraoperative Dexamethasone Implant Improves Outcome of Cataract Surgery With Diabetic Macular Edema	Phase 4
Completed	`NCT03169855` - Validation of Mesopic and Photopic Contrast Vision Tests With Respect to Nighttime Driving Ability
Terminated	`NCT03913130` - Extension Study to Study PQ-110-001 (NCT03140969)	Phase 1/Phase 2
Recruiting	`NCT03479021` - SPOT Vision Screening
Recruiting	`NCT05600140` - Viewing Strategy Training in Children With (Cerebral) Visual Impairment	N/A

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Bridging Animal and Human Models of Exercise-induced Visual Rehabilitation

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms